Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
13
×
national blog main
life sciences
startups
boston blog main
national top stories
new york blog main
san francisco blog main
boston top stories
boulder/denver blog main
national
new york top stories
san diego blog main
san diego top stories
san francisco top stories
wisconsin blog main
wisconsin top stories
boulder/denver top stories
detroit blog main
detroit top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
abbvie
biogen
clinical trials
crispr
deals
editas medicine
fda
gene editing
gilead sciences
glaxosmithkline
indiana blog main
indiana top stories
novartis
What
ceo
13
×
bio
company
drug
medical
roundup
acquisitions
announced
crispr
medicine
new
biggest
daniel
drugs
editas
financing
gilead
katrine
medicines
million
moves
names
old
o’day
pfizer
raised
research
sciences
today
week
year
years
accidentally
adds
admits
aims
ajay
albert
alex
allergan
Language
unset
unknown
Current search:
ceo
×
biotech
×
@techcrunch.com
2 years ago
Injectsense collects $1.7M grant for its eye implant smaller than a grain of rice
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@techcrunch.com
4 years ago
After selling Auris for $3.4 billion to J&J, CEO Frederic Moll and lead investor Ajay Royan come to Disrupt
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
NorthStar Names Merrick CEO, Appoints Hendricks as Board Chair
@xconomy.com
5 years ago
Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO
@techcrunch.com
7 years ago
Theranos closes its labs and wellness centers, lays off 340